chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have been experiencing a lot of joint pain and tinnitus. The joint pain seems to move around my body. When one place stops hurting another will start to hurt. It started with my right hip. The pain generally happens on the right side of my body. I went and saw my PCP and he referred me to physical therapy and told me to take anti-inflammatories. After my hip pain improved, my shoulder and elbow started to hurt. I feel that physical therapy is helping. I am not blaming the vaccine, but this did occur after receiving my booster. If we are in need to get another booster, I will still get it. I am very thankful for those that are doing all of this work with the vaccines.
This spontaneous report as received from a licensed practical nurse refers to an unknown number of patients of unknown age and gender. In an approximately November 2014 (also reported as between 17-NOV-2014 and 26-NOV-2014) the patients were vaccinated with an improperly stored PROQUAD (Merck) (route, dose, frequency and lot # not reported) that was supported with in-house stability data. No further information was provided. This is one of several reports from the same source. Additional information has been requested.
This case was reported by a consumer and described the occurrence of injection site redness in a 76-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). A physician or other health care professional has not verified this report. The subject's medical history included egg allergy as a child. On 6 November 2013, the subject received a dose of FLULAVAL (route unknown, right arm,  batch number not provided). At an unspecified time after vaccination with FLULAVAL, the subject experienced injection site redness, injection site warmth and after injection went white. It happened periodically, it turns warm, white and red and then faded away within minutes. At the time of reporting, the events were unresolved.
mild pain injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In October 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in her right arm and only experienced mild pain at the injection site. This case is linked to the case US2020AMR034844 reported for the 2nd dose.
restlessness; Lightheadedness; Diarrhea; slept all day; sensation and taste in her mouth was different; chills; Headache; very fatigued; This spontaneous case was reported by a consumer and describes the occurrence of RESTLESSNESS (restlessness), DIZZINESS (Lightheadedness), DIARRHOEA (Diarrhea), SOMNOLENCE (slept all day) and TASTE DISORDER (sensation and taste in her mouth was different) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0U1B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced HEADACHE (Headache) and FATIGUE (very fatigued). On 30-Mar-2021, the patient experienced RESTLESSNESS (restlessness), DIZZINESS (Lightheadedness), DIARRHOEA (Diarrhea), SOMNOLENCE (slept all day), TASTE DISORDER (sensation and taste in her mouth was different) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, RESTLESSNESS (restlessness), DIZZINESS (Lightheadedness), DIARRHOEA (Diarrhea), SOMNOLENCE (slept all day), TASTE DISORDER (sensation and taste in her mouth was different), HEADACHE (Headache), FATIGUE (very fatigued) and CHILLS (chills) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment medication included Tylenol for symptom alleviation.
?Pfizer-BioNTech COVID-19 Vaccine?   Vaccine administration error related to temperature excursion from recommended storage temperature, not known to this writer to be associated with an adverse event. The clinic has relayed to this writer that prior to the vaccine's thawing and administration to the vaccine recipient, the administered vaccine was stored in frozen temperatures for longer than recommended by the manufacturer. (This VAERS writer assigned to form completion was not the administrator of this vaccine).  Outcome: Vaccine recipient was contacted by staff.
This spontaneous report as received from a pharmacist via a company representative refers to a female patient of unknown demographics. The patient's current conditions or medical history were not reported. On 07-DEC-2013, the patient was vaccinated with a single dose of ZOSTAVAX vial (dose, route, lot and expiration date were not reported) for prevention of shingles. On an unknown date, it was reported that the patient experienced an unspecified rash at the injection site. The patient was recovered at the time of the report, the event improved after stopping therapy and the therapy was not reintroduced. This is one of several reports from the same source. Additional information has been requested.
Red bumps apx 1 1/2 in x 2 in Hot to touch
Patient Recieved Varivax vaccine as well as MMRV vaccine during the same visit.
Massive sore arm; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a female patient who received Flu unspecified (Flu vaccine) for prophylaxis.   Previously administered products included Flu vaccine with an associated reaction of pain in extremity (On an unknown date 1st dose received for tolerance of 1st dose refer case US2023AMR001645).   On an unknown date, the patient received the 2nd dose of Flu vaccine. On an unknown date, unknown after receiving Flu vaccine, the patient experienced pain in arm. Rechallenge with Flu vaccine was positive. On an unknown date, the outcome of the pain in arm was unknown.   The reporter considered the pain in arm to be possibly related to Flu vaccine.     Linked case(s) involving the same patient:  US2023AMR001645   Additional Information: GSK receipt date: 05-JAN-2023 Reporters comment: This case was reported by a consumer via interactive digital media. The patient received the flu vaccine twice in her life and stated that was not sick from that was a massive sore arm. The patient stated that she wanted to give his/her 16 month but not planned on getting it herself as she already caught a very nasty this year and felt 5 time worsened than the covid; Sender's Comments:  US-GSK-US2023AMR001645:same reporter
Metallic taste in mouth, tingling on lips.  Later in the week after the shot strange smells.  Rubber smells, and some unexplained
Malaise, burning pain in lt arm; pt given Medrol dose pack, lab work, Atarax; serum sickness, immune complex disease-mononeuritis multiplex;
Patient reported high fever(did not take temp), shivering and body aches 3 days post vaccination.Immunization injection sight WNL.  Symptoms lasted approximately 24 hours.
This spontaneous report as received from a nurse refers to an unspecified number of patient of unknown age and gender. It was reported that unknown number of doses of (Oka/Merck) VARIVAX were exposed to temperature of -14C for a few hours and then -10.2 C for less than 1 hour. It was reported that the doses might had been administered. No adverse effect was reported. Additional information has been requested.
Site: Redness at Injection Site-Mild, Systemic: PT FELL UPON LEAVING IMMUNIZATION ROOM BUT STATES IT HAD NOTHING TO DO WITH IMMUNIZATIONS.HER KNEE GAVE OUT, WHICH IT IS PRONE TO DOING ACCORDING TO THE PATIENT AND HER SISTER-IN-LAW, WHO CAME TO PICK HER UP. THIS FORM REQUIRED REACTION TYPE:CHOSE REDNESS-Mild, Systemic: Weakness-Mild
Pt recvd Td vax 7FEB92 & c/o lt deltoid red, given pain med; arm had hard center; 17FEB92 was seen by MD dx sterile abscess r/o osteomylitis; 18FEB92 prolonged local rxn, soreness;
Sharp pain/discomfort under right arm that began 5 days after receiving vaccine [7/29/21], then painful swelling of one supraclavicular lymph node right side 7/30/21 and a second swollen node above first one day after that [7/31/21]. Both also warm to the touch, felt slightly dizzy a few times, limited ROM and unable to sleep on right side due to it.
bladder spasms; one episode of diarrhea; headache; body aches; low grade fever/ fever of 101.6; injection site soreness; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 69-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On 07-OCT-2023, the patient received Arexvy. On 07-OCT-2023, less than a day after receiving Arexvy, the patient experienced injection site pain (Verbatim: injection site soreness) and fever (Verbatim: low grade fever/ fever of 101.6). On 08-OCT-2023, the patient experienced bladder spasm (Verbatim: bladder spasms), diarrhea (Verbatim: one episode of diarrhea), headache (Verbatim: headache) and general body pain (Verbatim: body aches).On 09-OCT-2023, the outcome of the injection site pain and fever were resolved (duration 2 days) and the outcome of the diarrhea, headache and general body pain were resolved (duration 1 day).The outcome of the bladder spasm was not resolved.   It was unknown if the reporter considered the injection site pain, bladder spasm, diarrhea, headache, general body pain and fever to be related to Arexvy.   It was unknown if the company considered the injection site pain, bladder spasm, diarrhea, headache, general body pain and fever to be related to Arexvy.   Additional Information: GSK Receipt Date: 10-OCT-2023 The reporter was the patient.  She received Arexvy the morning and had injection site soreness.  That evening she had a low grade fever.  The next day, she had a fever of 101.6, body aches, headache, one episode of diarrhea and bladder spasms.  All of these effects (except the bladder spasms) resolved in the morning of 9th October 2023.  The patient spoke with her doctor on 9th October 2023.  The doctor did not believe the bladder spasms were related to Arexvy.  A urinalysis was done and results were pending.  The bladder spasms continued.  Nothing else was reported. The reporter did not consent to follow-up.
patient got deathly ill after first flu shot n wound up in the hospital; Initial information was received on 24-Oct-2020 regarding an unsolicited valid serious social media case from a consumer (patient).  This case is linked to case 2020SA300788 (same reporter).  This case involves patient of an unknown demographics who got deathly ill after first flu shot n wound up in the hospital (malaise), while he/she received INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided.   On an unknown date, the patient received a first dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date were not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient got deathly ill (malaise) (unknown latency) following the administration of INFLUENZA VACCINE. The patient was hospitalized for this event on an unknown date. Consumer also stated that he/she would never get another dose and doctor also agreed not to get one again.  Laboratory data was not reported.  It was not reported if the patient received any corrective treatment or not.  The outcome of the event was not reported.; Sender's Comments: This poorly documented social media case concerns a patient of an unknown demographics who got deathly ill after vaccination with INFLUENZA VACCINE (produced by unknown manufacturer). The time to onset is unknown. The patient's medical history, medical condition at time of vaccination, concomitant medication and lab test ruling out alternate etiologies were not reported. Based upon the reported information, the role of vaccine cannot be assessed.
PEDS Bivalent vaccine given without being reconstituted first.  Pt receive 0.2 mL undiluted vaccine.  Pt was monitored, no adverse reactions noted.  Discussed with mother, advised regarding signs to monitor for.  Encouraged hydration, pain/fever reducer.  Contact provider with severe symptoms, trouble breathing.  Mother verbalized understanding.
Left deltoid red, swollen, warm to touch Dx Cellulitis. IM ROCEPHIN given.
I am quite really tired/I have never been this tired during the day time like I am right now; I fell asleep sitting in the chair/I feel like I took something that helped me to sleep; This is a spontaneous report from a contactable nurse (patient). A 66-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE: Batch/lot number: EJ1686), via an unspecified route of administration at deltoid left on 12Jan2021 at single dose for covid-19 immunization. Medical history included hypertension, diabetes, High cholesterol, asthma, Allergies, irritable bowel syndrome, depression. Concomitant medication included lisinopril, metoprolol, hydrochlorothiazide (HCTZ), glipizide, sitagliptin phosphate (JANUVIA), budesonide, formoterol fumarate (SYMBICORT Inhaler), montelukast sodium (SINGULAIR), montelukast, levocetirizine for allergies, levocetirizine dihydrochloride (XYZAL) for allergies, atorvastatin, dicycloverine (DICYCLOMINE), sertraline as anti-depressant, ascorbic acid, ergocalciferol, nicotinamide, retinol, riboflavin, thiamine hydrochloride (VITAMINS). The patient was quite really tired, she was trying to get walked on, so, she can work because she worked from home and she was sitting here, and she fell asleep sitting in the chair in front of computer. She tried to reach employee health at work, but they were helping in the shot clinic. She had never been this tired during the daytime like she was right now, she felt like she took something that helped her to sleep on 12Jan2021. The nurse did not visit any emergency room/ physician office. The patient had drunk coffee and was drinking diet coke for caffeine. No other treatment received for the events. The outcome of the events was unknown.
AG neg 3/13 positive 3/15; rhinorrhea; laryngitis; cough; AG neg 3/13 positive 3/15; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP).  A 40 year-old male patient received bnt162b2 (BNT162B2), administration date 12Oct2021 (Lot number: FF2589) at the age of 40 years as dose 3 (booster), single, administration date 25Feb2021 (Lot number: EL3247) as dose 2, single and administration date 05Feb2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "AG neg 3/13 positive 3/15"; RHINORRHOEA (non-serious) with onset 12Mar2022, outcome "unknown", described as "rhinorrhea"; LARYNGITIS (non-serious) with onset 12Mar2022, outcome "unknown", described as "laryngitis"; COUGH (non-serious) with onset 12Mar2022, outcome "unknown", described as "cough". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (13Mar2022) neg; (15Mar2022) positive. It was unknown if therapeutic measures were taken as a result of rhinorrhoea, laryngitis, cough. It was unknown if the patient had received any other vaccine in four weeks. It was unknown if the patient had covid prior to vaccination. No sensory involvement. Clinically stable from the onset of symptoms. Treatment with Immunoglobulin therapy at doses of 2g / kg - 77Kg (154g in total), from 22No2021 to 26Nov2021. Clinically the patient reports improvement in fine manipulation and in lower limbs. It was a chronic inflammatory demyelinating polyneuropathy vs Multifocal Motor Neuropathy vs Gillian-Barre Syndrome.  No follow-up attempts are possible. No further information is expected.
Provided 2nd dose of Covid-19 Vaccine, Moderna brand per CDC recommendations after 1st dose was inadvertently provided to the client on 03/15/2021. Clients mother was with client at this time and agreed to 2nd dose. No adverse reaction noted.
pain in the arm of the injection; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm of the injection) and CHILLS (chills) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced PAIN IN EXTREMITY (pain in the arm of the injection) and CHILLS (chills). At the time of the report, PAIN IN EXTREMITY (pain in the arm of the injection) had not resolved and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported treatment with Acetaminophen on 10-Apr-2021. No concomitant drugs were reported.   This case was linked to MOD-2021-073690, MOD-2021-073840 (Patient Link).
It was reported that a female inadvertently received Pnu-Immune vax. Within 2 hours, she developed an injection site reaction characterized by a 2-inch area of induration, pain, swelling, redness and warmth. Additional information received from the physician on May 16, 2000 indicated that the patient recovered.
C/o nausea 15 minutes after 2nd dose. Water given, rested 20 minutes, resolved.
Developed Shingles June 22, 2021; Rest and prescriptions (anti-viral and steroid medication), resolved pain after 3 weeks
Patient developed COVID-19 on 10/26/2021 and died on 11/4/2021.  Patient admitted to long term care facility 5/24/2021.  Required VAERS reporting for fully vaccinated patient with COVID death.
Rash that I noticed appeared 1 week later as it started to itch at vaccination  site
pt recvd vax 7DEC93 & 7DEC93 mom noticed swelling @ site hardened area aprpox 44cm-redened, sl tender to touch;
I began to feel shortness of breath when walking, tightness in my chest, for the same reason any physical effort made me feel like I was short of breath. (The day before I had presented the common symptoms such as fever, chills, arm pain, muscle pain) however this symptom was off the list, at 11:30 in the morning I had to go to an emergency clinic, they checked me with blood test, urine tests, medical exam, electrocardiogram, and chest X-ray. The doctor told me that everything was fine that I could leave. I had to pay a high bill at the hospital. The following 7 days the sensation was disappearing very slowly. However from day 8 it started again, until now on day 13, I still having sensation of shortness of breath when doing physical exercise, it is something that lasts and does not disappear.
Swelling of right eyelid. BP 159/89 (pulse 105). Took Benadryl.
Received vaccine on 1/5/2021 and is complaining of swollen and stiff left arm and inability to move the left arm. States pain is 10 on a 10-point pain scale . Has been on Advil and Tylenol with no relief
Received Smallpox vaccine on 06 Jan 2010 and on 13 Jan 2010 started having chest pains and then on 17 Jan 2010 has shortness of breath
I got so sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of illness (1st dose received on an unknown date, for tolerance of previous dose refer case US2022AMR120495).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR120495   Additional Information: GSK receipt date: 15-AUG-2022 Reporter's comments: This case was reported by patient via interactive digital media. The patient got so sick on the vaccines, but patient would do it again. The patient did not want shingles. The follow up would not be possible as contact details were not provided.; Sender's Comments:  US-GSK-US2022AMR120495:Same reporter
Patient reported experiencing left arm and shoulder pain since his flu shot on 10/21/19. He did not report the pain to Department of Public Health Services until 12/20/19. He stated that he believed the nurse injected the flu shot too high on his arm and caused the injury. He went to see a doctor just a few days before coming in to report it to the clinic and that he had an MRI scheduled.
TINNITUS STARTING R EAR ADVANCING TO BIL.  PERSISTED WO IMPROVEMNT TO POINT DIFFICULTY THINKING AND CONCENTRATING.  ALSO W GRADUAL ONSET OF HA THAT SEEMED TO CRESCENDO 10/16-19/2012 BUT STILL PERSIST AS CONSTANT HA 3-5 PAIN SCALE 1-10.
After giving Tdap and Hep A vaccines, patient had syncope, brief seizure activity lasting 3-4 minutes recovered and left clinic with parents. Per call the next morning no further problems
FATHER REPORTED TWO EPISODES OF "SHAKING" OF UPPER EXTEMITIES AND HEAD LASTING 10-15 SEC. NO RIGIDNESS, NO UNUSUAL EYE MOVEMENT, NO POST DROWSINESS, NORMAL BEHAVIOR FOLLOWING AND PRIOR TO EPISODE. FIRST EPISODE 2 DAYS POST VACCINE, SECOND EPISODE 1 WEEK POST VACCINE.
2.5" local redness, LLE, +1 tenderness, between injection sites.
Shivering uncontrollably, high fever above 102F, minor disorientation. Cleared up after 12 hours followed by severe headache. Painful joints /mucsles and loss of appitite along with bronchitis like symptoms. Still no appitite and chest congestion
This spontaneous report was received from a other registered nurse refers to a 4 month old patient (gender unknown). On an unknown date the patient was vaccinated with ROTATEQ dose 2 (dose unspecified). (lot # and exp date was unknown). The reporter stated that ROTATEQ was given to the patient 8 days after the expiration date. The reporter was concerned about the dose could be repeated if immediately or in 6 weeks. The patients outcome was unknown. Additional information has been requested.
PATIENT STATED THAT APPROXIMATELY 8 DAYS AFTER RECEIVING HER DOSE HER ARM BECAME WARM AND HAD  AN ITCHY RASH.  IT LASTED ABOUT 4 DAYS
No adverse event; incorrect Moderna covid19 vaccine strength administered.  Reported to on duty NP.  Directed to contact family to have client return to give correct Moderna covid19 vaccine.  Called and spoke with mom, over the phone and explained and apologized for incident and to bring child to be vaccinated with correct dose.  Mom stated she will speak with her husband first then will call our office to schedule an appointment.